Chiara Corti, MD

Apariciones en rankings

Los mejores días en que los posts de esta cuenta entraron en la lista diaria de Debya.

Esta cuenta aún no ha aparecido en un ranking diario.

Posts que le gustaron recientemente

Me gusta públicos de la red Bluesky.

• Sarat Chandarlapaty@saratchandarlapaty.bsky.social16-05-2025 12:14

  Published online today - work from our team led by Avantika Gupta, revealing how APOBEC3 mutagenesis promotes resistance to several targeted therapies in breast cancer. Check it out! urldefense.com/v3/__https:/...

  Ver post
• mitcriticaldata.bsky.social@mitcriticaldata.bsky.social16-04-2025 22:32

  In this paper, we found that the majority of AI mammogram studies come from high-income countries with no evaluation across patient demographics. Frustratingly but not surprisingly,developers of the models were predominantly men. Please, don't sell these algorithms to low-and-middle-income countries

  Ver post
• mitcriticaldata.bsky.social@mitcriticaldata.bsky.social16-04-2025 22:32

  The business model should be assisting health systems with creating and maintaining their data pipeline, their curation pipeline, their evaluation pipeline, and most importantly, their "learning pipeline".

  Ver post
• mitcriticaldata.bsky.social@mitcriticaldata.bsky.social16-04-2025 22:32

  www.sciencedirect.com/science/arti... If your business model is still selling algorithms, please stop. The accuracy of models is limited in time and space. The pursuit of generalizability is misguided. AI should be local, iterative, reflective and reflexive.

  Ver post
• Dana-Farber’s Breast Oncology Center@dfcibreastonc.bsky.social16-04-2025 02:35

  Don't miss this newly published review discussing recent advances in immune checkpoint inhibitors for #TripleNegativeBreastCancer. 🔓 pubmed.ncbi.nlm.nih.gov/40196378/ @ccortimd.bsky.social @stolaney1.bsky.social #TNBC #BreastCancer

  Ver post

Inicia sesión para ver más

Cuentas que bloquea

En Bluesky los bloqueos son registros públicos.

Esta cuenta no bloquea a nadie.